Atlas Trials

Proteome-based Personalized Immunotherapy of Glioblastoma

Clinical trial NCT01759810 · UNKNOWN

Trial details

NCT number
NCT01759810
Sponsor
NeuroVita Clinic
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Glioblastoma
Start date
2012-12-01
Primary completion
2018-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.